Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case-Control Study

Toxins (Basel). 2024 Jun 3;16(6):258. doi: 10.3390/toxins16060258.

Abstract

The goal-setting process is pivotal in managing patients with disabling spasticity. This case-control study assessed the role of diagnostic nerve blocks in guiding the goal-setting process within goal-targeted treatment of spasticity with botulinum neurotoxin-A. In this case-control study, patients with disabling spasticity underwent either a goal-setting process based on the patient's needs and clinical evaluation (control group) or additional diagnostic nerve block procedures (case group). All enrolled patients underwent a focal treatment with botulinum neurotoxin-A injection and a 1-month follow-up evaluation during which goal achievement was quantified using the goal attainment scaling-light score system. Data showed a higher goal achievement rate in the case group (70%) than in the control group (40%). In conclusion, diagnostic nerve blocks may help guide the goal-setting process within goal-targeted treatment of spasticity with botulinum neurotoxin-A towards more realistic and achievable goals, thereby improving the outcomes of botulinum neurotoxin-A injection. Future studies should better explore the role of diagnostic nerve blocks to further personalize botulinum neurotoxin-A according to individual patients' preferences and requirements.

Keywords: botulinum neurotoxin-A; diagnostic nerve block; goal-setting process; neurorehabilitation; personalized treatment; spasticity.

MeSH terms

  • Adult
  • Aged
  • Botulinum Toxins, Type A* / therapeutic use
  • Case-Control Studies
  • Goals
  • Humans
  • Male
  • Middle Aged
  • Muscle Spasticity* / diagnosis
  • Muscle Spasticity* / therapy
  • Nerve Block*
  • Neurological Rehabilitation* / methods

Substances

  • Botulinum Toxins, Type A

Grants and funding

This research received no external funding.